Hal H. Spinal Cord Injury Milestone
Another great day at Project Walk as Hal H. was nearly able knock his Specialist off his feet during controlled leg presses. Hal has been with Project Walk for over five years and continues to prove that although he was diagnosed as C5/6 complete, recovery is possible. Great job Hal!From:ProjectWalkSCIViews:30 0ratingsTime:00:54More inScience Technology

More here:
Hal H. Spinal Cord Injury Milestone - Video

Recommendation and review posted by sam

quot;The idea that someone with a spinal cord injury would be su
Andy is paralysed from the neck down after sustaining a spinal cord injury in his early twenties. Following the research findings from Loughborough University that highlight the devastating impact of housing spinal cord injured adults in care homes, Andy responds to the fact that this happens to 1 in 5 spinal cord injured people in the UK.From:Aspire CharityViews:8 0ratingsTime:02:59More inNews Politics

More here:
"The idea that someone with a spinal cord injury would be su - Video

Recommendation and review posted by sam

Back Up Exmoor weekend multi-activity course
Every October Back Up pushes the boundaries of people with spinal cord injuries through their multi-activity course in Exmoor. Participants get to try out a whole multitude of outdoor activites, including rock climbing, archery, hand cycling, horse riding and bushcraft. They also get the chance to gain valuable wheelchair skills training. The course is also an opportunity for corporate #39;buddies #39; to get involved, learn what it #39;s like to have a spinal cord injury and to make some great friendships.From:BackUpTrustViews:0 0ratingsTime:03:06More inNonprofits Activism

Link:
Back Up Exmoor weekend multi-activity course - Video

Recommendation and review posted by sam

Twins Make Donation to the Mary Free Bed Spinal Cord Injury Program
We first introduced you to Benton and Garret Truttman in a video post to Mary Free Bed #39;s Facebook page back on November 5th. The twins raised money at their eleventh birthday party to donate to the Mary Free Bed Spinal Cord Injury Program. At the time, their grandmother was a patient recovering from a spinal cord injury. This video shares more about Benton and Garret #39;s story and shows how the boys were able to help spread hope throughout the entire hospital.From:MaryFreeBedViews:6 0ratingsTime:03:54More inEducation

See the original post here:
Twins Make Donation to the Mary Free Bed Spinal Cord Injury Program - Video

Recommendation and review posted by sam

4th Annual SLU Hair Transplant Course: Platelet Rich Plasma (PRP) Acell
http://www.hairtx.com Dallas Hair Transplant Surgeon, Dr. Sam Lam, as Course Director of the 4th Annual St. Louis University Hair Transplant 360 Course, overviews how he uses regenerative medicine techniques with his hair transplants and independent of his hair transplants, specifically PRP (Platelet Rich Plasma) and Acell. Key words hair transplant, dallas, texas, hair restoration, course, dr. sam lam, regenerative medicine, prp, platelet rich plasma, acell, porcine bladderFrom:samlammdViews:2 0ratingsTime:13:22More inScience Technology

See the rest here:
4th Annual SLU Hair Transplant Course: Platelet Rich Plasma (PRP)

Recommendation and review posted by sam

Doctors Treat Dog Paralysis Using Nose Cell Transplant
In an amazing report, doctors treat dog paralysis with nose cell transplant. Scientists at Cambridge University #39;s Veterinary School working with the Medical Research Council #39;s Regenerative Medicine Centre have partially treated paralysis in dogs by injecting them with transplanted cells. All of the dogs had spinal injuries that left their back legs paralyzed. The cells that the scientists used were taken from the olfactory ensheathing cells in the lining of the dog #39;s noses. 34 dogs took part in the trial, with 23 of them having transplant cells injected into their paralyzed legs. The rest were used as a control group and were given a neutral fluid injection. None of the dogs in the control group gained any use of their legs, but many of the dogs that were given the transplant cells had improved movement capabilities. Co-author of the study, Professor Robin Franklin told the BBC: #39;Our findings are extremely exciting because they show for the first time that transplanting these types of cell into a severely damaged spinal cord can bring about significant improvement." This is the first study that shows cells taken from the nose can be used to treat severe spinal chord damage.From:GeoBeatsNewsViews:1 0ratingsTime:01:05More inNews Politics

Follow this link:
Doctors Treat Dog Paralysis Using Nose Cell Transplant - Video

Recommendation and review posted by sam

Talking About Art Young Adults Studying About Regenerative Medicine
This art will be for sale. The art is inspired by the possible prospect of radical life extension technologies and regenerative medicine. Encouraging young adults to studying these fields in college/university is also discussed here. idea-archive.net http Please subscribe to this channel, share this video with others, visit my websites and watch my other videos. Thanks for watching. Also, please checkout my Etsy store. http://www.etsy.com Comments are welcomed and encouraged. However, if they contain rudeness, disrespect or swear words, then they will likely be removed.From:APerfectUniverseViews:0 1ratingsTime:07:44More inEntertainment

Read the original here:
Talking About Art

Recommendation and review posted by sam

cord blood registry | The Development of Umbilical Cord Blood Stem Cell Therapy
http://www.cordbloodrecommendation.com These diseases include blood related, genetic and neurotic disorders. ""Banking the umbilical cord blood when your baby is born is a relatively new idea, the first operation using it to help cure a child with Leukemia was only done a little over 10 years ago. After processing of cells, comes the next procedure of cord blood preservation. There is also another option given by non-profit cord blood banks, of free programs through which one can store umbilical cord blood stem cell samples. A man can change his god-gifted features wishfully with the help of science. Given the progress that stem cell research and regenerative medicine have attained at present, and the promise that they show for the future, stem cell transplants may one day provide a cure for type 1 diabetes, heart disease, and brain injury, among other potentially life threatening and debilitating illnesses and conditions with inadequate treatment options today. With people not fully understanding how important stem cells could be for us, everybody agrees that more research need to be done in order to help understand all that. If there is any complication during delivery, the entire idea is abandoned. It is always wise to preserve this waste blood of the baby which is otherwise thrown away. You are injecting the patient with those same cells that created him!This can be done with the bone marrow transplants tooYes, stem cells are found in bone marrows too. It is a simple and ...From:luisantafeViews:0 0ratingsTime:01:31More inScience Technology

Read the original here:
cord blood registry | The Development of Umbilical Cord Blood Stem Cell Therapy - Video

Recommendation and review posted by Bethany Smith

Stem cells achieve sustained heart function improvement in heart attack patients
From Louisville - Stem cell therapy has been shown to sustain heart function improvement in heart attack patients in a phase 1 clinical presented at the AHA #39;s Scientific Sessions. The trial, known as SCIPIO for Stem Cell Infusion in Patients with Ischemic CardiOmyopathy, randomized 33 patients diagnosed with heart failure after suffering a heart attack to either cardiac stem cells or no stem cells. Researchers found that patients who received the stem cells had great improvement in their heart function, and that this improvement was sustained 2 years following infusion. Patients who did not receive stem cells had no improvement. There were no adverse effects of the treatment. One patient #39;s heart experienced such dramatic improvement that there was no sign of heart failure at all. Said Dr. Roberto Bolli, lead author of the study, "Anyone who looks at his heart now would not imagine that this patient was (ever) in heart failure or that he had a heart attack."From:insidermedicineViews:0 0ratingsTime:00:59More inScience Technology

View post:
Stem cells achieve sustained heart function improvement in heart attack patients - Video

Recommendation and review posted by Bethany Smith

NeoStem, Inc. (NYSE:NBS ("NeoStem" or the "Company"), an emerging leader in the fast growing cell therapy industry, today announced that it has been awarded a two year grant totaling $1,221,854 for "Repair of Bone Defects with Human Autologous Pluripotent Very Small Embryonic-Like Stem Cells (VSEL)", grant number 2R44DE022493-02A1, from the National Institute of Dental and Craniofacial Research (NIDCR), a division of the National Institutes of Health (NIH). This peer reviewed grant is to support a Phase 2 investigation and first approved NIH clinical study of VSELsTM in humans. The study will be headed by Denis O. Rodgerson, Ph.D., Director of Grants and Academic Liaison for NeoStem, in collaboration with co-investigators Drs. Russell Taichman and Laurie McCauley of the University of Michigan. Enrollment for this study is expected to begin in 2013.

This award will fund the evaluation of VSELTM stem cells as a potential treatment for periodontitis. The product candidate, an autologous therapy derived from a patient's own stem cells, is to be developed for use in the regeneration of bone tissue damaged by this disease. The award includes $706,682 for the first year and $515,172 for the second year of the project, and will cover the cost of the Investigational New Drug (IND) submission to the FDA for the product candidate.

Dr. Denis O. Rodgerson, Director of Grants and Academic Liaison for NeoStem, said, "We are pleased and honored that NIH has agreed to support further studies on bone regeneration by using VSELTM stem cells. This is an extension of our successful NIH funded collaboration with Dr. Taichman showing the production of human bone from human VSELsTM in a mouse model."

Periodontal disease is prevalent in the U.S. and affects up to 90% of the world population. The most severe cases of periodontal disease affect between 5% and 15% of the U.S. population, or between 15 and 47 million Americans. The incidence of periodontal disease is estimated to be between 1 and 3 million Americans annually, and growing at a 7% rate each year. Studies have shown that periodontal inflammation could have a role in the initiation or progression of coronary heart disease and stroke. Market research experts have estimated that severe periodontal disease represents a market between $1.25 and $1.5 billion annually.

Dr. Russell Taichman, Major Ash Collegiate Professor and Co-Director of the Scholars Program in Dental Leadership, Department of Periodontics & Oral Medicine, University of Michigan stated, "I am thrilled for the possibilities that this award opens. The chance to continue to partner with NeoStem to further develop regenerative therapies is significant. The validation that this award brings and the opportunity to establish a proof of concept, which may impact human health, is truly rewarding." Dr. Laurie McCauley, The William K. and Mary Anne Najjar Professor, Division of Periodontics Department of Periodontics and Oral Medicine, University of Michigan added, "This novel cell based therapeutic approach looks to validate scientifically sound pre-clinical studies and provide a vital translation to improved human patient care."

NeoStem has a worldwide exclusive license to VSEL technology which uses very small embryonic-like stem cells, a heterogeneous population of stem cells found in adult bone marrow that have properties similar to those of embryonic stem cells. NeoStem has shown that very small embryonic-like stem cells can be mobilized into the peripheral blood, enabling a minimally invasive means for collecting what it believes to be an important population of stem cells that may have the potential to achieve the positive benefits associated with embryonic stem cells without the ethical or moral dilemmas or the potential negative biological effects associated with embryonic stem cells.

Dr. Robin L. Smith, Chairman and CEO of NeoStem, added, "We are very excited about this important step of funding for what will be the first human clinical study for our VSELTM technology. Not only will this study expand our knowledge of how autologous cell therapy can treat periodontitis and other bone defects, but it represents a milestone for NeoStem as we move our development of VSELTM technology beyond animal models and into the clinic, paving the way for other potential VSELTM trials."

About NeoStem, Inc.

NeoStem, Inc. continues to develop and build on its core capabilities in cell therapy, capitalizing on the paradigm shift that we see occurring in medicine. In particular, we anticipate that cell therapy will have a significant role in the fight against chronic disease and in lessening the economic burden that these diseases pose to modern society. We are emerging as a technology and market leading company in this fast developing cell therapy market. Our multi-faceted business strategy combines a state-of-the-art contract development and manufacturing subsidiary, Progenitor Cell Therapy, LLC ("PCT"), with a medically important cell therapy product development program, enabling near and long-term revenue growth opportunities. We believe this expertise and existing research capabilities and collaborations will enable us to achieve our mission of becoming a premier cell therapy company.

Our contract development and manufacturing service business supports the development of proprietary cell therapy products. NeoStem's most clinically advanced therapeutic, AMR-001, is being developed at Amorcyte, LLC ("Amorcyte"), which we acquired in October 2011. Amorcyte is developing a cell therapy for the treatment of cardiovascular disease and is enrolling patients in a Phase 2 trial to investigate AMR-001's efficacy in preserving heart function after a heart attack. Athelos Corporation ("Athelos"), which is approximately 80%-owned by our subsidiary, PCT, is collaborating with Becton-Dickinson in the early clinical exploration of a T-cell therapy for autoimmune conditions. In addition, pre-clinical assets include our VSELTM Technology platform as well as our mesenchymal stem cell product candidate for regenerative medicine. Our service business and pipeline of proprietary cell therapy products work in concert, giving us a competitive advantage that we believe is unique to the biotechnology and pharmaceutical industries. Supported by an experienced scientific and business management team and a substantial intellectual property estate, we believe we are well positioned to succeed.

Read the original post:
NeoStem Receives Notification Of $1.2 million NIH Grant Award For First Clinical Study Of VSELTM Technology In Humans

Recommendation and review posted by Bethany Smith

MANILA, Philippines - A ranking official of the Catholic Bishops Conference of the Philippines (CBCP) considers immoral the embryonic stem cell therapy reportedly being used by politicians and actors for aesthetic purposes.

In an interview with Radio Veritas, CBCP-Episcopal Commission on Bioethics Chairman and Malolos Bishop Jose Oliveros said this medical procedure is against the belief of the Church. He said they are still assessing if the same could be said for stem cells from animals.

Pero yung sinasabi nila na pampabata sa mga politician at celebrities na sumailalim sa stem cell therapy ay immoral. Puwede namang ma-improve ang mukha ng isang tao, but it should be moral. Kapag gumamit ka ng immoral ay mali na yun, he said.

Embryo is still a maturing fetus.

He said the CBCP will come out with a pastoral statement regarding the matter once they are able to clarify certain matters with the Department of Health (DOH).

The DOH earlier warned people from using stem cells from aborted babies and human embryos.

The Philippine government will not allow the use of aborted fetuses or human embryosThere is a need to ensure that the biological raw materials are documented and validated and follow infection-free procedures, the DOH earlier said.

There is also a need to know if the materials to be injected came from animal or human tissues, it added.

Read more from the original source:
Stem cell therapy is immoral - bishop

Recommendation and review posted by Bethany Smith

People with particular variants of a gene known as FTO, the largest genetic factor behind obesity, are eight per cent less likely to suffer from depression, a new study found.

The findings, which are the first to link the gene with protection against depression, could help explain why some people are happier than others.

They question the common assumption that obesity and depression are mutually reinforcing that obese people are more prone to become depressed because of their appearance, and depressed people are more likely to gain weight because of a less active lifestyle and unhealthy eating habits.

Dr David Meyre, senior author of the study, said: "The difference of eight per cent is modest and it won't make a big difference in the day-to-day care of patients, but we have discovered a novel molecular basis for depression."

Previous research on twins and other siblings have suggested that depression may be up to 40 per cent hereditary, but no studies have been able to firmly link particular genes to the condition.

In the new study, the scientists examined data on 17,200 DNA samples donated by volunteers from 21 different countries as part of a wider project by the Population Health Research Institute.

They found that the variant in the FTO gene, which has already been shown to raise the risk of obesity, was also linked to a lower depression risk. The same link was later identified in three other large international studies.

Continue reading here:
Obesity gene linked to happiness

Recommendation and review posted by Bethany Smith

The search for genes predisposing people to depression has taken an unexpected twist, according to Canadian researchers who found a clue in an obesity gene.

Studies on families and twins suggest depression has a genetic component, but for 15 years, scientists haven't been able to find genes associated with the illness.

Researchers at McMaster University in Hamilton, Ont., took a different approach by testing how obesity genes may be linked with depression.

"We found the first gene predisposing to depression with consistent results," said David Meyre, an associate professor in clinical epidemiology and biostatistics at McMaster and a Canada Research Chair in genetic epidemiology.

In Monday's issue of the journal Molecular Psychiatry, Meyre and his co-authors reported that a variant of the FTO gene may be associated with a lower risk of depression independent of the gene's effect on obesity.

The common perception is that obese people become depressed because of their appearance and poor self-esteem or discrimination. Another common thought is that those who are depressed are less likely to be physically active or follow healthy eating habits. Taking antidepressants can also lead to weight gain.

But the genetic findings challenge that thinking, Meyre said, since those with the genetic mutation predisposing to obesity were protected from depression.

"This suggests that the FTO gene may have a broader role than initially thought with an effect on depression and other common psychiatric disorders," the researchers wrote.

The protective effect showed up not just once or twice but in four different studies of people of various ethnicities around the world.

In total, the researchers analyzed FTO gene mutations in 6,591 people with depression in standard screening and more than 21,000 others who werent diagnosed with depression.

Read the original here:
Obesity gene may help protect against depression

Recommendation and review posted by Bethany Smith

A new study suggests that early risers are more likely to pass away before lunchtime, whereas late sleepers tend to kick the bucket around dinner

Do you have an expiration date? A new study that examines the body's circadian rhythms suggests that while we might not be able to pinpoint the day you'll die, we might be able to get a rough idea of the time of day. Here's what you should know:

First off: What's a circadian rhythm? The body's internal clock that regulates what time we wake up, when we feel most awake, and what time we start feeling sleepy. Each individual's rhythm is sensitive to outside factors like daylight and time zone changes, though recent studies have demonstrated that gene mutations can also cause a person's circadian rhythms to vary. That's why some people are "morning people" while others can barely get themselves out of bed. And now, a new study from the neurological department of the Beth Israel Deaconess Medical Center (BIDMC) in Boston claims that we can use these gene mutations to assess what time of day a person might die.

How was this research conducted? Researchers combed through 15 years of data from a sleep study originally conducted at Rush University in Chicago. This study took a look at roughly 500 seniors over age 65, all of whomwore an actigraph, which closely tracks your sleeping habits. Many of the subjects also had their DNA collected, and had physical and psychological evaluations performed. Before the study was finished, many of the participants had also died providing researchers with many subjects' exact time of death.

What did researchers discover? First, certain nucleotides helped determine each subject's natural sleeping patterns. For example: People with the genotype "A-A" tended to be early risers, waking up a full hour earlier than people on the other end of the spectrum, or late sleepers born with the genotype "G-G." Most of us fall somewhere in the middle with a gene configuration "A-G" a full 48 percent of us are born with this broader, A-G configuration and tend to wake up sometime between the early birds and the late sleepers.

How do these gene patterns relate to death? This is where things get a little weird: People born with either an A-A or A-G genotype tended to die just before 11 a.m; Late sleepers with a G-G genotype, on the other hand, generally died just before 6 p.m.

Why is this?"Virtually all physiological processes have a circadian rhythm" including death, says BIDMC Chief of Neurology Clifford Saper. Researchers speculate that as the elderly patients inched closer to death's door, their usual social commitments became less of a factor in their daily lives, allowing their circadian rhythms to assert more authority and the times of their death to be dictated, at least in part, by their genes.

Sources: The Atlantic, Herald Sun, Red Orbit, Science Blog

SEE ALSO: Are you more likely to die of a heart attack during winter?

View this article on TheWeek.com Get 4 Free Issues of The Week

See original here:
The gene that may predict the time of day you'll die

Recommendation and review posted by Bethany Smith

SANTA CLARA, Calif.--(BUSINESS WIRE)--

Affymetrix, Inc. (AFFX) today announced a research and service collaboration with the Centre for Proteomic and Genomic Research (CPGR) in South Africa. CPGR will provide gene expression and Axiom genotyping services to African researchers using GeneTitan Multi-Channel (MC) Instrument. The Affymetrix and CPGR partnership aims to enable high-throughput genomics research and personalized medicine projects across Africa.

The CPGR is a nonprofit organization funded by the Technology Innovation Agency (TIA), which is based on an initiative by the Department of Science and Technology (DST) whose goal is to develop the bio-economy in South Africa. According to Dr Reinhard Hiller, Managing Director of the CPGR, The high throughput capability of GeneTitan MC Instrument combined with customizable Axiom Genotyping Arrays is ideal for meeting the needs of scientists in Africa whose research projects range from small pilot to large-scale discovery to focused validation studies. GeneTitan MC Instrument expands our genomics service capabilities and will further enable CPGR to support cutting-edge translational research in Africa. Further, it allows discovery and validation of disease-related biomarkers economically even when searching for very rare genetic variants. We expect to progress personalized medicine studies that aim to discover genetic markers specific in the African population for better diagnosis and drug treatment.

It is a well-known fact that genetic variability of African populations is far greater than in other regions in the world. This is particularly important when considering that African populations are underrepresented in most studies on hereditary diseases and pharmacogenomics. Applying these types of genomic discoveries to clinical practices has the potential to change health and wellness of African populations.

We are excited to partner with CPGR and see this as a significant opportunity to ensure that African populations are represented in genomics research studies leading to personalized therapies. Affymetrix is leading the way in population optimized genotyping analysis and was the first to create a genotyping array with content derived specifically from African populations, said Chris Barbazette, VP of Commercial Operations, International Markets at Affymetrix.

Products mentioned in this release are for research use only. Not for diagnostic procedures.

PLEASE NOTE: Affymetrix, the Affymetrix logo, Axiom, GeneChip, GeneTitan, QuantiGene, SensationPlusTM, and all other trademarks are the property of Affymetrix, Inc. All other trademarks are the property of their respective owners.

About the CPGR

The CPGR is a specialist not-for-profit contract research organization established in South Africa through funding by the Technology Innovation Agency (TIA) to provide support and services to the life science and biotech community. It is based on an initiative by the Department of Science and Technology (DST) to boost the development of a bio-economy in South Africa. The CPGR combines state-of-the-art information rich genomic and proteomic ('omics') technologies with bio-computational pipelines, and biological models, to create unique solutions in the human health and the agri-biotech sectors. Please visit http://www.cpgr.org.za for more information or contact Dr Reinhard Hiller at reinhard.hiller@cpgr.org.za.

About Affymetrix

Read the original here:
Affymetrix Announces Research Collaboration With Centre for Proteomic and Genomic Research (CPGR) in South Africa

Recommendation and review posted by Bethany Smith

London, Nov 21 (IANS)

A specific gene could explain why fat people are happier than their thinner counterparts, says a new research from McMaster University, Canada.

Scientists have linked the "fat gene" with the "happy gene". "Strictly" star Lisa Riley has recently said she is a "big, really happy girl who is lucky enough to be confident in her own skin".

The FTO gene is the major contributor to obesity, but it is also linked with an eight percent reduction in the risk of depression, the Daily Mail reports.

McMaster researchers investigated the genetic and psychiatric status of patients enrolled in the EpiDREAM study, led by the population Health Research Institute, and analysed 17,200 DNA samples from participants in 21 countries.

Results showed those with the previously identified fat gene FTO showed significantly less signs of depression. These findings were confirmed by analysing the genetic status of patients in three additional international studies.

David Meyre, professor at McMaster, said: "We set out to follow a different path, starting from the hypothesis that both depression and obesity deal with brain activity. We hypothesised that obesity genes may be linked to depression."

"The difference of eight percent is modest and it won't make a big difference in the day-to-day care of patients. But we have discovered a novel molecular basis for depression," added Meyre.

Original post:
Gene keeps fat people happier than skinny ones

Recommendation and review posted by Bethany Smith

Mathematician Terry Speed has been honoured with the Victoria Prize for life sciences. Photo: Simon O'Dwyer

THINK not of him as a policeman preventing scientists from going down the wrong research road. Instead mathematician Terry Speed opens new paths of investigation for researchers by highlighting trends or anomalies buried in dense data.

''A lot of people perceive me as being the policeman but I don't like being cast in that role,'' he said. ''I would rather be the person who illuminates things and unlocks information.''

For his trouble Professor Speed was awarded the $50,000 Victoria Prize for life sciences at a ceremony at the State Library on Wednesday.

Ana Deletic has won the award for physical sciences. Photo: Simon O'Dwyer

Biology experiments generate masses of data. Things get complicated quickly and it doesn't take long for scientists to call in the experts.

Advertisement

That's where bioinformatics comes in. A biologist can present Professor Speed with a question or problem - such as finding the difference between a normal breast cell and a cancerous breast cell - and it's his job to unlock the genetic secrets hidden in the data.

''It's often the case that genes which shouldn't be being expressed are, or genes which should be being expressed aren't,'' he said. ''We need to find which it is. But there are 30,000 genes and we don't want to look through each one, one at a time.''

The Walter and Eliza Hall Institute's resident statistician creates tailored algorithms and programs to hunt out the answers to specific questions.

Continued here:
Gene data guru and stormwater expert win top prize

Recommendation and review posted by Bethany Smith

Perhaps there is a bit of truth to the stereotype about being fat and happy new research finds that people who have a gene linked with obesity may have a slightly lower risk of depression.

People who had a version of a gene called the FTO gene were 8 percent less likely to have depression, researchers found. In 2007, scientists discovered this version of the FTO gene was a major contributor to genetic obesity among people of European descent.

The finding "suggests that the FTO gene may have a broader role than initially thought, with an effect on depression and other common psychiatric disorders," the researchers wrote in their study published today (Nov. 20) in the journal Molecular Psychiatry.

The researchers said the findings challenge the idea that obesity and depression are generally linked. Some have suggested that obese people become depressed because of their appearance and discrimination, while people with depression may become less active and change their eating habits to cope with their illness.

"The difference of 8 percent is modest, and it won't make a big difference in the day-to-day care of patients," study researcher David Meyre, associate professor in clinical epidemiology and biostatistics at McMaster University in Canada, said in a statement. "But, we have discovered a novel molecular basis for depression," Meyre said.

The researchers looked at data gathered on more than 17,000 people who participated in a genetics study between 2001 and 2003. About 3,200 of the participants had depression. The researchers further supported the link they found by analyzing data on genes of patients in three additional large international studies.

Still, further studies are needed to confirm the findings, they said.

Previous studies of families have suggested that 40 percent of the risk of depression comes from genetics, the researchers said. However, attempts to find specific genes associated with depression have not produced convincing evidence so far, according to the study.

This finding is important because about 9 percent of U.S. adults have depression at any given time, according to estimates from the Centers for Disease Control and Prevention.

Pass it on: A gene linked with obesity may help protect people against depression.

Continued here:
Obesity Gene May Shield Against Depression

Recommendation and review posted by Bethany Smith

e.coli
Stand Up Comedian, Michael Freed, discusses genetic engineering. Scientists are doing so much with genetic engineering. They might even solve the energy crisis. They #39;ve created e. coli bacteria that actually breaks down organic material and produces 100% pure diesel fuel. That #39;s all well and good but what happens when that breaks free of the lab? The symptoms of the next e. coli outbreak could include spontaneous combustion. It brings a whole new meaning to the words explosive diarrhea.From:Michael FreedViews:0 0ratingsTime:00:43More inComedy

See the rest here:
e.coli - Video

Recommendation and review posted by Bethany Smith

malaria
Stand Up Comedian, Michael Freed, discusses genetic engineering. Scientists in California have genetically altered mosquitos whose immune systems kill the malaria parasite. That is just incredible news for mosquitos. This is going to revolutionize their way of life. They can feed with impunity without any fears of killing of their food source. Think of what it will do for their reputation. Now all the scientists have to do is catch and genetically modify every mosquito on the planet and malaria will be completely wiped out. Forgive me for thinking they #39;re going about this the wrong way. Don #39;t you think it might be a little easier to boost the human immune system to kill malaria? I #39;m thinking the 3 billion willing participants in malaria prone areas would be a whole lot easier to round up than the 95 bazillion unwilling mosquitoes. Why don #39;t we just cross the great wall of china by going around while we #39;re at it.From:Michael FreedViews:0 0ratingsTime:00:57More inComedy

More here:
malaria - Video

Recommendation and review posted by Bethany Smith

Science in Focus Genetic Engineering
From:LammasScienceViews:11 0ratingsTime:19:12More inEducation

Go here to see the original:
Science in Focus Genetic Engineering - Video

Recommendation and review posted by Bethany Smith

10 Genetic Engineering Part 1
From:Studio151videoViews:0 0ratingsTime:55:58More inEducation

Read the rest here:
10 Genetic Engineering Part 1 - Video

Recommendation and review posted by Bethany Smith

10 Genetic Engineering Part 2
From:Studio151videoViews:0 0ratingsTime:56:46More inEducation

The rest is here:
10 Genetic Engineering Part 2 - Video

Recommendation and review posted by Bethany Smith

Primordial Slime
Primordial Slime is one of 23 prototypes being pitched for Double Fine #39;s public Amnesia Fortnight. Vote to get this project made and check out the other prototypes at http://www.humblebundle.com Primordial slime is new way to interact with a character on your touch/mobile device. Use gestures to push and pull on a piece of living slime, flinging it through the air and splattering it against objects in a mad laboratory filled with physics puzzles, traps and abominations of science! You, the slime, awaken resting in a Petri dish inside a self destructing laboratory. Explore your way through a maze of physics puzzles while uncovering the mystery of the experiment that both brought you to life as well as brought doom to the lab. Travel through a world filled with physics puzzles you #39;ll need to experiment with to solve and navigate through, while eluding traps built to capture wild experiments. In primordial slime, you #39;ll need to fend for your newly gained sentient life against other experiments and abominations, who thanks to the wonder of science, range from incredibly cute octopus cats to vicious spider tailed tiger eels, or whatever other genetic engineering monstrosities science is capable of creating.From:DoubleFineProdViews:7567 52ratingsTime:00:32More inGaming

More:
Primordial Slime - Video

Recommendation and review posted by Bethany Smith

Prelude To The Terraforming of Earth From The Visitors
Hello, this is the no face movement with my Vlog of my up and coming series called the terraforming of earth from the visitors. They know about the central galitic plain lining up with earth the know the collision of are solar system from the gravity pull of the central galitic plan, they know about the effects of the super flare one after another that opens portal that NASA Admitted, they know how to terraform are earth like we know how to terraform mars with pollution from factories, Haarp, chem trails, the collapse of the world economy, death prison camps for the humans with there eyes open, genetic engineering of food that genetic engineer of human body also from medicine vaccines, they know we love tech we love enter-tainment we go to programs or watch programs. Who are these visitor we will soon know with two years of documented evidence from collaboration of other you tubers scientists and metaphysic researchers. This is the movement moving a movement facing off.From:nofacemovementViews:1 1ratingsTime:05:10More inScience Technology

See the article here:
Prelude To The Terraforming of Earth From The Visitors - Video

Recommendation and review posted by Bethany Smith